PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 763.00
-7.00 (-0.91%)
Feb 2, 2026, 1:35 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 284.78 billion as of January 30, 2026. Its market cap has increased by 26.37% in one year.
Market Cap
284.78B
Enterprise Value
264.09B
Revenue
13.82B
Ranking
n/a
PE Ratio
59.46
Stock Price
763.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 284.78B, an increase of 623.09%. That is a compound annual growth rate of 18.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 284.78B | 63.83% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 94.94B |
| Bora Pharmaceuticals Co., LTD. | 74.79B |
| Center Laboratories | 30.09B |
| TTY Biopharm Company | 21.21B |
| ScinoPharm Taiwan | 19.49B |
| Alar Pharmaceuticals | 18.00B |
| Grape King Bio | 17.92B |
| Synmosa Biopharma | 16.25B |